Redefining the Standard of Cancer Care
Cancer care is being rewritten. To deliver cutting-edge patient care and lead the field, healthcare professionals need a definitive guide to the clinical discoveries reshaping oncology.
The latest edition of AMJ Oncology is now live, distilling high-impact insights and the biggest breakthroughs from ASCO 2026 – spanning pancreatic, lung, breast, and prostate cancers – into a concise, actionable format.
Driving the Future of Oncology
We cut through the noise to bring you the evidence-based research shifting clinical practice today:
- Deadly Diagnoses, Doubled Survival: Discover the groundbreaking new drug doubling survival rates in one of medicine’s most challenging oncological prognoses.
- Curative Intent in Breast Cancer: Explore why a powerful HER2-positive breast cancer therapy is being deployed earlier in the treatment pathway—when a cure is still the ultimate goal.
- Sparing Chemotherapy: Are we on the brink of sparing thousands of breast cancer patients aggressive chemotherapy they never actually needed?
- Multidisciplinary Breakthroughs: Essential clinical updates spanning lung, pancreatic, and prostate cancer management.
Expert Analysis, Fully Accessible
Featuring exclusive coverage and unmissable clinical insights, this issue is backed by over 100 world-class contributors. We believe the advancements shaping the future of cancer care should be fully open-access for every practitioner driving the field forward.
This is the knowledge your peers are already reading. It’s free, it’s vital, and it’s available now.
